The cost of the opioid crisis to the U.S Healthcare System

This study examines the financial burden of the opioid crisis on the United States healthcare system using a system-oriented, multivariate empirical framework. Drawing on survey data from 387 healthcare facilities and professionals, the study models Financial Cost Pressure as a function of opioid-related demand, emergency department burden, treatment capacity and access, hospital response strategies, reporting and surveillance timeliness, workforce and operational strain, drug market complexity, community and social determinants, and analytics and early warning readiness. Results indicate that opioid-related demand and emergency department burden are the strongest drivers of cost pressure, while workforce strain, reporting challenges, drug market complexity, and adverse social conditions further amplify financial burden. In contrast, greater treatment capacity, stronger hospital response strategies, and improved analytic readiness significantly mitigate system-level costs. The model explains 63 per cent of financial cost pressure. By integrating epidemic dynamics and institutional capacity, the study provides evidence on sustained healthcare costs.